Postmortem redistribution of the enantiomers of citalopram and its metabolites: an experimental study in rats
2004 (English)In: Journal of Analytical Toxicology, ISSN 0146-4760, Vol. 28, no 8, 631-637 p.Article in journal (Refereed) Published
A rat model was used to study if postmortem redistribution of the S- and R-enantiomers of citalopram (CIT) and its metabolites demethylcitalopram (DCIT) and didemethylcitalopram (DDCIT) occurs after three different subcutaneous dosing procedures with racemic CIT. Two groups underwent chronic administration (20 mg/kg daily) using osmotic pumps. After 10 days, 1 of these groups received an acute-on-chronic drug challenge with a single injection of 100 mg/kg. The third group received the single 100 mg/kg dose only. Heart blood and brain samples were collected antemortem and 1, 3, or 24 h postmortem for enantioselective HPLC analysis. Increased postmortem blood drug and metabolite concentrations compared with corresponding antemortem concentrations were observed in all groups (p < 0.05 to p < 0.001). At 24 h after death, the ratios between postmortem and antemortem blood concentrations were around 3–4 for CIT as well as for the metabolites. In the brain, no major differences between antemortem and postmortem drug and metabolite concentrations were observed. The enantiomeric (S/R) concentrations ratios of CIT and metabolites in blood and brain were of similar magnitude before and after death. No differences between antemortem and postmortem parent drug-to-metabolite (P/M) ratios for CIT/DCIT in blood were observed. Finally, this animal model demonstrates that the S- and R-enantiomers of CIT and its metabolites were redistributed to the same extent postmortem.
Place, publisher, year, edition, pages
2004. Vol. 28, no 8, 631-637 p.
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:liu:diva-24023DOI: 10.1093/jat/28.8.631Local ID: 3578OAI: oai:DiVA.org:liu-24023DiVA: diva2:244339